Data protection Impressum

Personalized Medicine

Top Stories Western Switzerland

Business environment

Top Stories from Western Switzerland (March 2024)

26 March 2024

This funding is poised to extend the company's financial runway into mid-2025, as it gears up for the approval and launch of pioneering products designed to enhance the lives of individuals with spinal cord injuries (SCI).

ONWARD Medical secures EUR 20 million to expand its spinal cord injury therapies

26 March 2024

This financial infusion is set to bolster the clinical advancement of Volumina Medical’s injectable dermal filler, Adipearl.

Volumina Medical raises USD 21 million to advance regenerative medicine

25 March 2024

The ARTORG team investigates how a special balloon catheter must be used so that drugs can reach and dissolve blood clots in the smallest branches. To do this, they combine engineering know-how, fluid mechanics and biological expertise.

Bern researchers unveil groundbreaking cardiac care method

19 March 2024

Alithea Genomics, which emerged from the EPFL in 2020, has distinguished itself within the life sciences sector with its cutting-edge RNA sequencing solutions.

Alithea Genomics embarks on next-phase growth with CHF 2.8 million funding

18 March 2024

Neuria not only offers a promising solution for behavioral modification but also provides extensive services to health-related companies and the scientific community.

Neuria enters Vanguard Accelerator to gameify healthier lifestyles

12 March 2024

Argá Medtech's technology assesses the safety and effectiveness of coherent sine wave electroporation in patients with atrial fibrillation.

Argá Medtech secures EUR 54 million towards its atrial fibrillation treatment

6 March 2024

This investment propels Aktiia's mission to address the global challenge of hypertension, which affects over 1.4 billion individuals worldwide and is responsible for more than 18 million deaths annually.

Aktiia secures CHF 27 million to combat global hypertension crisis

4 March 2024

SmellRS is developing an ambitious and innovative technology for the early detection of Alzheimer's disease and the restoration of the sense of smell.

FONGIT Innovation Fund backs HeroSupport and SmellRS to advance healthcare innovation

4 March 2024

CSEM and ClexBio, a Nordic startup specializing in regenerative medicine, has developed a novel bioreactor capable of cultivating human veins in the laboratory.

CSEM and ClexBio unveil groundbreaking bioreactor to advance cardiovascular treatment

26 February 2024

1 2 3 4 5 6 7 8 9 10 … 17